Loading
Banner
PORTFOLIO OVERVIEW

KEY CATEGORIES IN OUR STERILE PORTFOLIO

Filter Alphabetically by Product Name

110 Products Found

Acetaminophen Injection SDV
Acetylcysteine (200mg/mL - Vial)
Acyclovir Sodium (50mg/mL - Vial)
Adenosine (3mg/mL - Vial)
Amphotericin B Liposome Injection
Ampicillin (10g - PFS)
Ampicillin and Sulbactam (15g - PBP(PFS))
Anastrozole (1mg - Tablets)
Argatroban Injection in 0.9% Sodium Chloride (1mg/mL - Vial)
Arsenic Trioxide (2mg/mL - Vial)
Azithromycin (500mg/Vial - Lyo)
Bivalirudin Injection
Bortezomib (3.5mg/Vial - Lyo)
Bromfenac (0.09% w/v - Ophthalmic Solution)
Bupivacaine (0.25% (2.5mg/mL), and 0.5% (5mg/mL) - Ampoule)
Load More

INNOVATION AND FUTURE EXPANSION

At Eugia Pharma, we are constantly innovating our sterile injectable portfolio to meet the growing healthcare needs of patients worldwide. Through continuous R&D and clinical research, we aim to expand our portfolio, offering innovative solutions in critical care and beyond.

qualityinnov-bgimg
Quality and Safety in Sterile Manufacturing

Quality and Safety in Sterile Manufacturing

Each of our sterile injectables is manufactured in state-of-the-art facilities that comply with Good Manufacturing Practices (GMP). Our products undergo rigorous testing to ensure efficacy, stability, and safety. We follow the highest industry standards for production and packaging, ensuring that each product is reliable for both healthcare professionals and patients.

Innovating for the Future of Critical Care

We continually innovate and expand our sterile injectable portfolio to address the growing and diverse needs of global healthcare. Our focus on patient safety, quality control, and scientific research enables us to provide new therapies for critical care, meeting the demands of healthcare professionals worldwide.

Innovating for the Future of Critical Care